| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 3, 2002
From the Microbiology and Tumor Biology Center (A.E., R.C., Y.C.), the Center for Genomics and Bioinformatics (C.W.), and the Department of Cell and Molecular Biology (J.T.), Karolinska Institute, Stockholm, Sweden; the Department of Surgical Sciences (J.R.), Karolinska Hospital, Stockholm, Sweden; and the Department of Medical Physiology (K.T., S.D.), The Panum Institute, University of Copenhagen, Copenhagen, Denmark. * To whom correspondence should be addressed. E-mail: yihai.cao{at}mtc.ki.se.
Background--Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) induces both angiogenesis and vascular permeability. Although its angiogenic activity has been well characterized, the signaling pathways of VEGF-induced permeability remain poorly understood. Methods and Results--Using the mouse corneal micropocket assay, Miles assay, and a combination of cytochemical, electron microscopic, and biochemical assays, we demonstrate that VEGF-induced vascular leakage partly can be separated from its angiogenic activity. VEGF but not FGF-2 induced capillaries with a highly fenestrated endothelium, a feature linked with increased vascular permeability. A cell-permeable Rac antagonist (TAT-RacN17) converted VEGF-induced, leaky vascular plexuses into well-defined vascular networks. In addition, this Rac mutant blocked formation of VEGF-induced endothelial fenestrations and vascular permeability but only partially inhibited angiogenesis. Studies on endothelial cell cultures further revealed that VEGF stimulated phosphorylation of VEGF receptor-2 (VEGFR-2), leading to activation of Rac as well as increased phosphorylation of phospholipase C Conclusions--Our findings indicate that the small GTP-binding protein Rac is a key component in mediation of VEGF-induced vascular permeability but less so in neovascularization. This may have conceptual implications for applying Rac antagonists in treatment and prevention of VEGF-induced vascular leakage and edema in connection with ischemic disorders.
Revised on November 27, 2002
Accepted on December 3, 2002
Small GTP-Binding Protein Rac Is an Essential Mediator of Vascular Endothelial Growth Factor-Induced Endothelial Fenestrations and Vascular Permeability
Anna Eriksson PhD,
(PLC
), protein kinase B (Akt), endothelial nitric oxide synthase (eNOS), and extracellular regulated kinase (Erk1/2). We further found that phosphatidylinositol-3-OH kinase (PI3K) acted upstream of Rac and Akt-eNOS in VEGF/VEGFR-2 signaling.
This article has been cited by other articles:
![]() |
C. Y. Cheung and R. A. Brace Hypoxia Modulation of Caveolin-1 and Vascular Endothelial Growth Factor in Ovine Fetal Membranes Reproductive Sciences, May 1, 2008; 15(5): 469 - 476. [Abstract] [PDF] |
||||
![]() |
M. Gossl, L. O. Lerman, and A. Lerman Frontiers in Nephrology: Early Atherosclerosis A View Beyond the Lumen J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2836 - 2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Genis, P. Gonzalo, A. S. Tutor, B. G. Galvez, A. Martinez-Ruiz, C. Zaragoza, S. Lamas, K. Tryggvason, S. S. Apte, and A. G. Arroyo Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells Blood, October 15, 2007; 110(8): 2916 - 2923. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tritsaris, M. Myren, S. B. Ditlev, M. V. Hubschmann, I. van der Blom, A. J. Hansen, U. B. Olsen, R. Cao, J. Zhang, T. Jia, et al. IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs PNAS, September 25, 2007; 104(39): 15364 - 15369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ioannidou, K. Deinhardt, J. Miotla, J. Bradley, E. Cheung, S. Samuelsson, Y.-S. Ng, and D. T. Shima From the Cover: An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis PNAS, November 7, 2006; 103(45): 16770 - 16775. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lu, E. O. Harrington, H. Jackson, N. Morin, C. Shannon, and S. Rounds Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation J Appl Physiol, August 1, 2006; 101(2): 375 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wojciak-Stothard, L. Y. F. Tsang, E. Paleolog, S. M. Hall, and S. G. Haworth Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1173 - L1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gonzalez, R. Kou, and T. Michel Rac1 Modulates Sphingosine 1-Phosphate-mediated Activation of Phosphoinositide 3-Kinase/Akt Signaling Pathways in Vascular Endothelial Cells J. Biol. Chem., February 10, 2006; 281(6): 3210 - 3216. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Lee, K. Man, J. W. Ho, X. H. Wang, R. T.P. Poon, Y. Xu, K. T. Ng, A. C. Chu, C. K. Sun, I. O. Ng, et al. FTY720: A Promising Agent for Treatment of Metastatic Hepatocellular Carcinoma Clin. Cancer Res., December 1, 2005; 11(23): 8458 - 8466. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cao, A. Hong, H. Schulten, and M. J. Post Update on therapeutic neovascularization Cardiovasc Res, February 15, 2005; 65(3): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Stockton, E. Schaefer, and M. A. Schwartz p21-activated Kinase Regulates Endothelial Permeability through Modulation of Contractility J. Biol. Chem., November 5, 2004; 279(45): 46621 - 46630. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. J. Leenders, B. Kusters, K. Verrijp, C. Maass, P. Wesseling, A. Heerschap, D. Ruiter, A. Ryan, and R. de Waal Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option Clin. Cancer Res., September 15, 2004; 10(18): 6222 - 6230. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mayer, G. Boileau, and M. Bendayan Sorting of Furin in Polarized Epithelial and Endothelial Cells: Expression Beyond the Golgi Apparatus J. Histochem. Cytochem., May 1, 2004; 52(5): 567 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao, and J. Thyberg Comparative Evaluation of FGF-2-, VEGF-A-, and VEGF-C-Induced Angiogenesis, Lymphangiogenesis, Vascular Fenestrations, and Permeability Circ. Res., March 19, 2004; 94(5): 664 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lu, E. O. Harrington, C.-M. Hai, J. Newton, M. Garber, T. Hirase, and S. Rounds Isoprenylcysteine Carboxyl Methyltransferase Modulates Endothelial Monolayer Permeability: Involvement of RhoA Carboxyl Methylation Circ. Res., February 20, 2004; 94(3): 306 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Stamatovic, R. F. Keep, S. L. Kunkel, and A. V. Andjelkovic Potential role of MCP-1 in endothelial cell tight junction `opening': signaling via Rho and Rho kinase J. Cell Sci., November 15, 2003; 116(22): 4615 - 4628. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cerimele, L. F. Brown, F. Bravo, G. M. Ihler, P. Kouadio, and J. L Arbiser Infectious Angiogenesis: Bartonella bacilliformis Infection Results in Endothelial Production of Angiopoetin-2 and Epidermal Production of Vascular Endothelial Growth Factor Am. J. Pathol., October 1, 2003; 163(4): 1321 - 1327. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |